Vitroscope

Company Description

TS received, EU deep tech VC leads 3m € seed round - ckriesi@vitroscope.no for more info Vitroscope is building the App Store of Life Science to fundamentally change how we understand human health. 2m€ revenue in the pipeline for 2024. Our customers already use our technology to ellicit a human response from 2D, tissue, and organoid models in the laboratory. Controlled, recorded, and analysed in the cloud. We have now signed the verticals of drug R&D, personalized medicine, and IVF.